Survey Brief: Economic Problems Facing Families April 28, 2008 Poll Finding This poll finds that health care costs rank among Americans’ top personal economic problems, and their struggles to deal with those costs have affected both their financial well-being and their family’s health care. Conducted by the Foundation’s public opinion researchers, the poll probes into the economic concerns facing Americans and…
KFF Health Tracking Poll: Economic Views and Experiences of Adults Who Struggle Financially February 21, 2024 Poll Finding Half of adults say they have difficulty affording monthly bills or are just able to afford household expenses without having money left over. These groups overwhelmingly rate the economy negatively and are more likely to want 2024 presidential candidates to discuss economic issues.
The Affordability of Long-Term Care and Support Services: Findings from a KFF Survey November 14, 2023 Poll Finding This survey shows that most adults feel unprepared for affording the cost of long-term care and support service, and just under half are not confident they will have the financial resources to pay for care they might need as they age. Most older adults have not taken financial or practical steps to plan for their potential future care needs.
KFF Health Tracking Poll February 2024: Voters on Two Key Health Care Issues: Affordability and ACA February 21, 2024 Poll Finding This poll finds that inflation and health care affordability are the top issues voters want 2024 presidential candidates to discuss, as most rate the economy negatively. Adults worry most about affording unexpected medical bills and health care costs, and the Affordable Care Act remains popular despite partisan differences when it comes to its future.
Public Opinion on Prescription Drugs and Their Prices August 21, 2023 Poll Finding This chart collection draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices.